(Q40612612)

22 September 2017

title

Effects of Herceptin treatment on global gene expression patterns in HER2-amplified and nonamplified breast cancer cell lines (English)

1 reference

22 September 2017

2

1 reference

22 September 2017

Päivikki Kauraniemi

1

1 reference

22 September 2017

Reija Autio

3

1 reference

22 September 2017

Jaakko Astola

4

1 reference

22 September 2017

Outi Monni

5

1 reference

22 September 2017

Abdel Elkahloun

6

1 reference

22 September 2017

Anne Kallioniemi

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

22 September 2017

number of pages

4

1 reference

inferred from page(s)

published in

Oncogene

1 reference

22 September 2017

volume

23

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

1010-1013

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207200

22 September 2017

exact match

0 references

cites work

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

Ratio-based decisions and the quantitative analysis of cDNA microarray images

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

Robust Locally Weighted Regression and Smoothing Scatterplots

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

Analysis and Visualization of Gene Expression Microarray Data in Human Cancer Using Self-Organizing Maps

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207200

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207200

1 reference

Dimensions Publication ID

22 September 2017

1032100297

0 references

1 reference